Member List

NameCountryWebsiteWGERC code Techniques of expertise Research interests
Alves, Isabel
U. of Bordeaux
PTWG1, WG21. Molecular biophysics
2. Biological chemistry
3. Psychiatric disorders
  • Biophysical/plasmon waveguide resonance
  • Biochemical/signal transduction cascades
  • Biophysical/Calorimetry

1. lipid impact in signal transduction
2. ligand-receptor interaactions
3. cryo EM, sensor technologies, in cell FRET
Kandemis, Emine
Bahçeşehir University
TRhttps://bit.ly/2MNhRKqWG21. Molecular mechanisms of signalling pathways
2. Cell signalling and signal transduction
3. Non-coding RNAs
  • Computational
  • Computational
  • Computational

1. Cancer Biology
2. Cell signaling
3. LncRNAs
Corminboeuf, Olivier
Idorsia Pharmaceuticals Ltd
FRwww.idorsia.comWG1, WG2, WG3, WG41. Medicinal chemistry
2. Immunological mechanisms in disease
3. Pharmacology and pharmacogenomics
  • Chemistry
  • Biochemical
  • Pharmacology

1. Medicinal Chemistry
2. Oncology
3. Immunology
Carlsson, Jens
Uppsala University
SEhttp://www.carlssonlab.org WG3, WG4, WG51. Bioinformatics
2. Medicinal chemistry
3. Theoretical and computational chemistry
  • Computational
  • Computational
  • Computational

1. Polypharmacology/Selective/Biased ligands
2. Structural basis of GPCR activation
3. Accurate structural models of ALL GPCRs
Mordalski, Stefan
University of Copenhagen
DKWG1, WG31. Molecular mechanisms of signalling pathways
2. Structural biology and its methodologies (e.g. crystallography, cryo-EM, NMR and new technologies)
Up to three techniques of expertise - First
  • Computational
  • Computational
  • Computational

Contino, Marialessandra
University of Bari
ITWG3, WG41. Biological chemistry
2. Molecular mechanisms of signalling pathways
3. Neurological disorders
  • Pharmacology
  • Biochemical
  • Cell biology

1. GPCRs
2. Cancer
3. Neurodegeneration
Sommer, Martha
Charité Medical University Berlin
DEhttps://biophysik.charite.deWG1, WG21. Molecular mechanisms of signalling pathways
2. Molecular biophysics (e.g. single-molecule approaches, bioenergetics, fluorescence)
3. Biochemistry
  • Biophysical
  • Biochemical
  • Biochemical

1. Arrestin activation mechanism
2. Arrestin-GPCR interactions
3. Biological roles of arrestin
Hamann, Jörg
Amsterdam University Medical Centers
NLWG21. Immunological mechanisms in disease
2. Regulation and effector functions of the immune response
3. Molecular mechanisms of signalling pathways
  • Cell biology
  • Animal models
  • Clinical

1. Adhesion GPCRs
2. Microglia
3. T cells
Bennett, Kirstie
Sosei Heptares
GBwww.soseiheptares.comWG31. Molecular Biology, Biochemistry, Structural Biology and Molecular Biophysics
2. Cellular and Developmental Biology
3. Mathematics (applications in science and industry)
  • Pharmacology
  • Cell biology
  • Computational

1. GPCR
2. Molecular Pharmacology
Tautermann, Christofer
Boehringer Ingelheim Pharma GmbH & Co KG
ALWG2, WG31. Theoretical and computational chemistry
2. Medicinal chemistry
3. Scientific computing, simulation and modelling tools
  • Computational
  • Structural
  • Computational

1. Drug design
2. Computational chemistry
3. GPCR models
Chabbert, Marie
CNRS
FRWG11. Computational biology
2. Molecular mechanisms of signalling pathways
3. Bioinformatics
  • Computational
  • Structural
  • Biophysical

1. GPCR
2. Biased Signaling
3. Molecular Simulations
Canals, Meritxell
University of Nottingham
GBWG1, WG2, WG3, WG41. Molecular mechanisms of signalling pathways
2. Pharmacology and pharmacogenomics (including drug discovery and design)
3. Molecular biophysics (e.g. single-molecule approaches, bioenergetics, fluorescence)
  • Pharmacology
  • Cell biology
  • Biochemical

1. Opioid receptors
2. GPCRs
3. Signalling
Liebscher, Ines
Leipzig University
DEWG1, WG21. Molecular Biology, Biochemistry, Structural Biology and Molecular Biophysics
2. Molecular mechanisms of signalling pathways
3. Biochemistry
  • Biochemical
  • Pharmacology
  • Animal models

1. Adhesion GPCR
2. Mechano-activation
3. Deorphanization
Solano, Maria Marti
MRC Laboratory of Molecular Biology
GBWG1, WG31. Molecular mechanisms of signalling pathways
2. Computational biology
3. Systems biology
  • Computational
  • Structural
  • Pharmacology

1. Pharmacogenomics
2. Signalling bias
3. Structural Biology
Kolb, Peter
Philipps-University Marburg
DEwww.kolblab.orgWG3, WG51. Pharmacology and pharmacogenomics (including drug discovery and design)
2. Medicinal chemistry
3. Scientific computing, simulation and modelling tools
  • Computational
  • Structural
  • Pharmacology

1. Ligand selectivity
2. Prediction of affinity/efficacy/bias
3. Chemical universe
Hauser, Alexander
University of Copenhagen
DKWG1, WG2, WG3, WG4, WG51. Bioinformatics
2. Systems biology
3. Pharmacology and pharmacogenomics (including drug discovery and design)
  • Computational
  • Structural
  • Biophysical

1. GPCRs
2. Pharmacogenomics
3. Structure Biology
Fardilha, Margarida
University of Aveiro
PTwww.ua.ptWG2, WG31. Biochemistry
2. Genetics, ’Omics’, Bioinformatics and Systems Biology
3. Physiology, Pathophysiology and Endocrinology
  • Biochemical
  • Cell biology
  • Clinical

1. Male reproduction
2. Sperm motility
3. Protein phosphatase 1
Žerovnik, Eva
Institute "Jožef Stefan"
SIWG1, WG3, WG4, 1. Physical chemistry of biological systems
2. Biological chemistry
3. Nanophysics
  • Biochemical
  • Biophysical
  • Cell biology

1. Protein folding
2. Protein aggregation
3. Cascade of neurodegeneration
Lazar, Josef
Institute of Organic Chemistry and Biochemistry CAS
CZwww.uochb.czWG1, WG2, WG3, WG41. Molecular biophysics (e.g. single-molecule approaches, bioenergetics, fluorescence)
2. Cell signalling and signal transduction
3. Spectroscopic and spectrometric techniques
  • Biophysical
  • Cell biology
  • Structural

1. Cell signaling
2. Advanced optical microscopy
3. G proteins
Plouffe, Bianca
Queen's University Belfast
GBhttps://pure.qub.ac.uk/WG2, WG31. Cell signalling and signal transduction
2. Fundamental mechanisms underlying cancer
3. Fundamental mechanisms underlying cardiovascular diseases
  • Pharmacology
  • Cell biology
  • Cell biology

1. Compartmentalised G protein signalling
2. GPCR signalling
Paparde, Artūrs
Rīga Stradiņš university
LVwww.rsu.lvWG21. Fundamental mechanisms underlying cardiovascular diseases
2. Comparative physiology and pathophysiology
3. Organ physiology and pathophysiology
  • Computational
  • Computational
  • Computational

1. Atherosclerosis
2. Cardiovascular adaptation
3. (Patho-) physiology of atherosclerosis
Kellenberger, Esther
Université de Strasbourg
FRhttp://bioinfo-pharma.u-strasbg.frWG31. Molecular Biology, Biochemistry, Structural Biology and Molecular Biophysics
2. Medicinal chemistry
3. Scientific computing, simulation and modelling tools
  • Computational
  • Structural
  • Structural

1. Molecular recognition
2. Structure-activity relationship
3. G-protein coupled receptor
D'Ursi, Pasqualina
National Research Council
ITwww.tb.cnr.itWG11. Molecular architecture and structure
2. Bioinformatics
3. Medicinal chemistry
  • Structural
  • Biochemical
  • Pharmacology

1. Bionformatics
2. Protein structure activity
3. Drug design
Tobin, Andrew
University of Glasgow
GBWG21. Cell signalling and signal transduction
2. Neural cell function, communication and signalling, neurotransmission
3. Pharmacology and pharmacogenomics (including drug discovery and design)
  • Biochemical
  • Pharmacology
  • Cell biology

1. Neuroscience
2. Gut physiology
3. Respiratory disease
Radi, Marco
University of Parma
IThttps://sites.google.com/site/marcoradiWG31. Medicinal chemistry
2. Method development in chemistry
3. Organic chemistry
  • Chemistry
  • Small molecules
  • Docking

1. CCR6
2. CXCR4
3. GPER-1
Murga, Cristina
Universidad Autónoma de Madrid
EShttp://cmurga.cbmso.esWG2, WG31. Cell signalling and signal transduction
2. Metabolism, biological basis of metabolism-related disorders
3. Organ physiology and pathophysiology
  • Biochemical
  • Animal models
  • Cell biology

1. Signalling
2. Pathophysiology
3. Metabolism
Nativi, Cristina
University of Florence
ITwww.unifi.itWG31. Organic chemistry
2. Glycomics/Lipidomics
3. Glycobiology
  • Chemistry
  • Computational
  • Computational

1. In vitro tests
2. Animal model
3. Glycobiology
Osborne, Greg
Heptares Therapeutics
GBwww.soseiheptares.comWG1, WG2, WG3, WG41. Mathematics (applications in science and industry)
2. Mathematics (applications in science and industry)
3. Mathematics (applications in science and industry)
  • Computational
  • Computational
  • Computational

Sotelo, Eddy
University of Santiago de Compostela
EShttps://www.sotelolab.esWG2, WG3, WG41. Medicinal chemistry
2. Biological chemistry
3. Fundamental aspects of synthetic biology and chemical biology
  • Chemistry
  • Chemistry
  • Pharmacology

1. Optimization of new ligands
2. New conjugation strategies
3. Biasedligands, allosteric modulators and bitopic ligands
Tate, Chris
MRC Laboratory of Molecular Biology
GBhttps://www2.mrc-lmb.cam.ac.uk/WG1, WG41. Molecular Biology, Biochemistry, Structural Biology and Molecular Biophysics
2. Macromolecular complexes
3. Structural biology and its methodologies (e.g. crystallography, cryo-EM, NMR and new technologies)
  • Structural
  • Biophysical
  • Biochemical

1. GPCR complexes
2. Structure
3. Dynamics
Bermudez, Marcel
Freie Universität Berlin
DEhttps://www.bcp.fu-berlin.deWG1, WG3, WG51. Pharmacology and pharmacogenomics (including drug discovery and design)
2. Medicinal chemistry
3. Molecular mechanisms of signalling pathways
  • Computational
  • Computational
  • Computational

1. GPCR pharmacology
2. Rational drug design
3. Signal tranduction
Capiod, Thierry
Université Paris-Descartes
FRhttps://www.institut-necker-enfants-malades.fr/WG2, WG31. Cellular and Developmental Biology
2. Physiology, Pathophysiology and Endocrinology
3. Immunity and Infection
  • Cell biology
  • Cell biology
  • Biophysical

1. Prostate
2. Cancer
3. Calcium
Gmeiner, Peter
FAU
DEhttp://www.medchem.fau.de/gmeinerlab/WG31. Medicinal chemistry
2. Neurological disorders
3. Imaging for medical diagnosis
  • Chemistry
  • Pharmacology
  • Computational

1. GPCR ligands
2. Drug discovery
3. Structure based design
Krasel, Cornelius
Philipps-University Marburg
DEhttps://www.uni-marburg.de/de/fb16/ipkpWG11. Molecular mechanisms of signalling pathways
2. Cell signalling and signal transduction
3. Mathematics (applications in science and industry)
  • Pharmacology
  • Biochemical
  • Cell biology

Tikhonova, Irina
Queen's University Belfast
GBhttps://pure.qub.ac.uk/WG1, WG3, WG51. Computational biology
2. Fundamental aspects of synthetic biology and chemical biology
3. Biochemistry
  • Computational
  • Biochemical
  • Pharmacology

1. Allosteric sites
2. Dimerization
3. Drug design
Dubiel, Mariam
Heinrich Heine University of Duesseldorf
DEhttp://www.pharmazie.hhu.deWG11. Pharmacology and pharmacogenomics (including drug discovery and design)
2. Neurological disorders
3. Molecular mechanisms of signalling pathways
  • Pharmacology
  • Biochemical
  • Chemistry

Wessel Andressen, Kjetil
University of Oslo
NOhttps://www.med.uio.no/WG11. Molecular biophysics (e.g. single-molecule approaches, bioenergetics, fluorescence)
2. Molecular mechanisms of signalling pathways
3. Macromolecular complexes
  • Biophysical
  • Biophysical
  • Pharmacology

1. cGMP
2. 5-HT7 receptor
3. Cardiomyocyte
Stefanachi, Angela
Università degli studi di Bari Aldo Moro
IThttps://www.uniba.it/WG3, WG41. Medicinal chemistry
2. Organic chemistry
3. Chemical reactions: mechanisms, dynamics, kinetics and catalytic reactions
  • Chemistry
  • Cell biology
  • Computational

1. CB2
2. Cancer
3. Neurodegeneration
Stark, Holger
Heinrich Heine University Düsseldorf
ALhttp://www.pharmazie.hhu.deWG1, WG2, WG31. Cell signalling and signal transduction
2. Glycomics/Lipidomics
3. Neural cell function, communication and signalling, neurotransmission
  • Chemistry
  • Pharmacology
  • Biochemical

1. Medicinal Chemistry
2. Drug development
3. Neurotransmitter
Cong, Xiaojing
Université Côte d'Azur
FRWG1, WG2, WG31. Theoretical and computational chemistry
2. Physical chemistry of biological systems
3. Bioinformatics
  • Computational
  • Biophysical
  • Chemistry

Nyagulova Kandemish, Emilia
Bahçeşehir University
ALhttp://akademik.bahcesehir.edu.trWG21. Molecular mechanisms of signalling pathways
2. Non-coding RNAs
3. Cell signalling and signal transduction
  • Cell biology
  • Cell biology
  • Cell biology

1. Cell signaling
2. Cancer
3. Non-coding RNAs
Gloriam, David
University of Copenhagen
DKWG3, WG51. Web and information systems, database systems
2. Theoretical and computational chemistry
3. Structural biology and its methodologies (e.g. crystallography, cryo-EM, NMR and new technologies)
  • Computational
  • Structural
  • Pharmacology

1. Open access databases
2. Computational drug design
3. Structure determination
M Keseru, György
Research Center for Natural Sciences
HUhttp://medchem.ttk.hu/WG31. Medicinal chemistry
2. Fundamental aspects of synthetic biology and chemical biology
3. Theoretical and computational chemistry
  • Chemistry
  • Chemistry
  • Computational

1. Medicinal chemistry
2. Chemical biology
3. Drug design
Rafael Franco
Universitat de Barcelona
ALWG1, WG21. Biological chemistry
2. Biochemistry
3. Neural cell function, communication and signalling, neurotransmission
  • Biochemical
  • Pharmacology
  • Biophysical
leroy xavier
Domain Therapeutics
FRwg1, wg2, wg3, wg4, wg51. Innate immunity
2. Innate immunity
3. Immunological mechanisms in disease
  • Pharmacology
  • Biochemical
  • Animal models
1. Immuno-oncology
2. GPCRs
3. Antibodies
Springael Jean-Yves
Université Libre de Bruxelles
ALhttps://iribhm.org/wg1, wg2, wg3, wg4, wg51. Cell signalling and signal transduction
2. Cell signalling and signal transduction
3. 9. Immunity and Infection
  • Pharmacology
  • Biochemical
  • Biophysical
1. GPCR
2. chemokine
3. BRET
Kiec-Kononowicz Katarzyna
Jagiellonian University
PLwg1, wg2, wg3, wg4, wg51. 1. Mathematics (applications in science and industry)
2. 1. Mathematics (applications in science and industry)
3. 1. Mathematics (applications in science and industry)
  • Computational
  • Computational
  • Computational
1. medicinal chemistry
2. GPCRs
3. drug-like properties
Filipek Slawomir
University of Warsaw
PLhttp://www.chem.uw.edu.pl/en/wg1, wg2, wg3, wg4, wg51. Biocomputing and molecular computation
2. Biocomputing and molecular computation
3. Molecular mechanisms of signalling pathways
  • Computational
  • Computational
  • Computational
1. GPCRs
2. signaling and biased signaling
3. ligand gated ion channels
Deupi Xavier
Paul Scherrer Institute
CHwww.psi.chwg1, wg2, wg3, wg4, wg51. Molecular architecture and structure
2. Molecular architecture and structure
3. Molecular mechanisms of signalling pathways
  • Computational
  • Structural
  • Biophysical
1. G protein-coupled receptors
2. Membrane proteins
3. Protein structure and dynamics
Uldrijan Stjepan
Masaryk University
CZhttps://www.muni.cz/enwg1, wg2, wg3, wg4, wg51. Cell signalling and signal transduction
2. Cell signalling and signal transduction
3. Cell cycle, division and growth
  • Cell biology
  • Biochemical
  • Pharmacology
1. Cell signaling
2. ERK pathway
3. Melanoma
Leurs Rob
Vrije Universiteit
falsewg1, wg2, wg3, wg4, wg51. 1. Mathematics (applications in science and industry)
2. 1. Mathematics (applications in science and industry)
3. 1. Mathematics (applications in science and industry)
  • Pharmacology
  • Chemistry
  • Computational
1. histamine receptors
2. chemokine receptors
Sztyler Agnieszka
Charité Medical University Berlin
DEhttps://biophysik.charite.dewg1, wg2, wg3, wg4, wg51. Biochemistry
2. Biochemistry
3. Molecular mechanisms of signalling pathways
  • Biochemical
  • Biophysical
  • Structural
1. GPCR
2. arrestin
3. signal transduction
Sztyler Agnieszka
Charité Medical University Berlin
DEhttps://biophysik.charite.dewg1, wg2, wg3, wg4, wg51. Biochemistry
2. Biochemistry
3. Molecular mechanisms of signalling pathways
  • Biochemical
  • Biophysical
  • Structural
1. GPCR
2. arrestin
3. signal transduction
Prömel Simone
Universität Leipzig
DEhttp://biochemie.medizin.uni-leipzig.de/mbch_cms/index.php/ag/ag-proemelwg1, wg2, wg3, wg4, wg51. Biochemistry
2. Biochemistry
3. Developmental genetics in animals and plants
  • Cell biology
  • Biochemical
  • Animal models
1. Adhesion GPCRs
2. Signalling
3. Physiological functions
Tahk Maris-Johanna
University of Tartu
EEhttp://gpcr.ut.ee/wg1, wg2, wg3, wg4, wg51. Cell signalling and signal transduction
2. Cell signalling and signal transduction
3. Biochemistry
  • Biochemical
  • Biochemical
  • Biochemical
1. Cell signaling pathways
2. Ligand-receptor interactions
3. Biosensors
Laasfeld Tõnis
University of Tartu
EEhttp://gpcr.ut.ee/wg1, wg2, wg3, wg4, wg51. Method development in chemistry
2. Method development in chemistry
3. Systems biology
  • Pharmacology
  • Pharmacology
  • Computational
1. deep learning for bioimage analysis
2. superresolution microscopy
3. kinetic models of ligand binding
Ler Daria
Eurofarm Centar Polyclinic
falsehttps://eurofarmcentar.ba/wg1, wg2, wg3, wg4, wg51. Molecular mechanisms of signalling pathways
2. Molecular mechanisms of signalling pathways
3. Proteomics
  • Clinical
  • Biochemical
  • Cell biology
1. molecular biomarkers
2. cancer biology
3.
Villà-Freixa Jordi
Universitat Internacional de Catalunya
ALhttp://www.uic.catwg1, wg2, wg3, wg4, wg51. Chemical reactions: mechanisms, dynamics, kinetics and catalytic reactions
2. Chemical reactions: mechanisms, dynamics, kinetics and catalytic reactions
3. Fundamental aspects of synthetic biology and chemical biology
  • Computational
  • Chemistry
  • Structural
1. Enzyme catalysis
2. Molecular modelling
3. Protein interactions
Laurenzana Anna
University of Florence
ITwg1, wg2, wg3, wg4, wg51. Molecular mechanisms of signalling pathways
2. Molecular mechanisms of signalling pathways
3. Cell junctions, cell adhesion, cell communication and the extracellular matrix
  • Cell biology
  • Biochemical
  • Clinical
1. cell biology
2. molecular biology
3. cancer
Moreira Irina
Coimbra University
PTwww.moreiralab.comwg1, wg2, wg3, wg4, wg51. Computational biology
2. Computational biology
3. Machine learning
  • Computational
  • Chemistry
  • Structural
1. Deep-learning
2. Drug discovery
3. GPCR function-structure
García Nafría Javier
Institute of Biocomputation and Physics of Complex Systems, University of Zaragoza
ESwg1, wg2, wg3, wg4, wg51. Structural biology and its methodologies (e.g. crystallography, cryo-EM, NMR and new technologies)
2. Structural biology and its methodologies (e.g. crystallography, cryo-EM, NMR and new technologies)
3. Macromolecular complexes
  • Structural
  • Biophysical
  • Biochemical
1. membrane protein complexes
2. structural biology
3. cryo-EM
Hanson Julien
University of Liège
BEhttps://www.gigamolphar.uliege.be/cms/c_4241240/en/portail-gigamolpharwg1, wg2, wg3, wg4, wg51. Cell signalling and signal transduction
2. Cell signalling and signal transduction
3. Pharmacology and pharmacogenomics (including drug discovery and design)
  • Pharmacology
  • Pharmacology
  • Cell biology
1. orphan GPCR
2. Endocrinology
3. Metabolism
Frank Philippe
University of Tours
FRhttps://n2c.univ-tours.fr/wg1, wg2, wg3, wg4, wg51. Fundamental mechanisms underlying cancer
2. Fundamental mechanisms underlying cancer
3. Fundamental mechanisms underlying cardiovascular diseases
  • Animal models
  • Cell biology
  • Biochemical
1. Breast Cancer
2. Cholesterol metabolism
3. Atherosclerosis
Frank Philippe
University of Tours
FRwg1, wg2, wg3, wg4, wg51. Fundamental mechanisms underlying cancer
2. Fundamental mechanisms underlying cancer
3. Fundamental mechanisms underlying cardiovascular diseases
  • Animal models
  • Cell biology
  • Biochemical
1. Breast Cancer
2. Cholesterol metabolism
3. Atherosclerosis
Garcia-Sosa Alfonso T.
University of Tartu
EEhttps://hermes.chem.ut.ee/~alfx/index.htmlwg1, wg2, wg3, wg4, wg51. Theoretical and computational chemistry
2. Theoretical and computational chemistry
3. Medicinal chemistry
  • Computational
  • Computational
  • Computational
1. drug design
2. drug discovery
3. molecular simulation
MOREAU Christophe
CNRS
FRwg1, wg2, wg3, wg4, wg51. Applied biotechnology (including transgenic organisms, applied genetics and genomics, biosensors, bioreactors, microbiology, bioactive compounds)
2. Applied biotechnology (including transgenic organisms, applied genetics and genomics, biosensors, bioreactors, microbiology, bioactive compounds)
3. Molecular biophysics (e.g. single-molecule approaches, bioenergetics, fluorescence)
  • Biophysical
  • Biochemical
  • Biochemical
1. electrical bionsensors
2. GPCRs
3. ion channel reporter
CASTEL Hélène
University Rouen Normandie
FRhttp://dc2n.labos.univ-rouen.fr/index.php/equipe-3wg1, wg2, wg3, wg4, wg51. Molecular mechanisms of signalling pathways
2. Molecular mechanisms of signalling pathways
3. Neural cell function, communication and signalling, neurotransmission
  • Cell biology
  • Animal models
  • Behavioral
1. Neuro-oncology
2. animal behavior
3. Cancer
Vrecl Fazarinc Milka
University of Ljubljana, Veterinary faculty
SIhttps://www.vf.uni-lj.si/wg1, wg2, wg3, wg4, wg51. Cell signalling and signal transduction
2. Cell signalling and signal transduction
3. Morphology and functional imaging of cells and tissues
  • Cell biology
  • Biophysical
  • Cell biology
1. GPCRs
2. protein-protein interactions
3. ntracellular signaling
Erol Ismail
Gebze Technical University
TRwg1, wg2, wg3, wg4, wg51. Molecular mechanisms of signalling pathways
2. Molecular mechanisms of signalling pathways
3. Biocomputing and molecular computation
  • Computational
  • Structural
  • Biophysical
1. GPCRs
2. Molecular simulations
3. oligomerization
Misicka-Kesik Alekssandra
University of Warsaw
PLwg1, wg2, wg3, wg4, wg51. Medicinal chemistry
2. Medicinal chemistry
3. Analytical chemistry
  • Chemistry
  • Pharmacology
  • Computational
1. bifuncional peptidomimetics
2. MOR, DOR
3. melanocortin MC4 receptors
Sencanski Milan
Vinča Institute of Nuclear Sciences
RShttps://www.vin.bg.ac.rs/180/wg1, wg2, wg3, wg4, wg51. Scientific computing, simulation and modelling tools
2. Scientific computing, simulation and modelling tools
3. Molecular mechanisms of signalling pathways
  • Computational
  • Computational
  • Computational
1. GPCRs
2. Chronic and infectious diseases
3. Drug repurposing
Daver Henrik
University of Copenhagen
DKwg1, wg2, wg3, wg4, wg51. Theoretical and computational chemistry
2. Theoretical and computational chemistry
3. Molecular mechanisms of signalling pathways
  • Computational
  • Computational
  • Computational
1. Protein-protein interactions
2. Computational drug design
Bradley Sophie
University of Glasgow
GBwg1, wg2, wg3, wg4, wg51. Cell signalling and signal transduction
2. Cell signalling and signal transduction
3. 1. Mathematics (applications in science and industry)
  • Pharmacology
  • Behavioral
  • Animal models
Bradley Sophie
University of Glasgow
GBwg1, wg2, wg3, wg4, wg51. Cell signalling and signal transduction
2. Cell signalling and signal transduction
3. 1. Mathematics (applications in science and industry)
  • Pharmacology
  • Behavioral
  • Animal models
Wolber Gerhard
Freie Universitaet Berlin
DEhttp://www.drug-design.dewg1, wg2, wg3, wg4, wg51. Medicinal chemistry
2. Medicinal chemistry
3. Artificial intelligence, intelligent systems, multi agent systems
  • Computational
  • Structural
  • Pharmacology
1. Mechanistic understanding of efficacy & bias
2. Tailored ligand design & optimization
3. Virtual screening techniques using molecular dynamics simulations
Tunaru Sorin
Institute of Biochemistry, Romanian Academy
ALwg1, wg2, wg3, wg4, wg51. Pharmacology and pharmacogenomics (including drug discovery and design)
2. Pharmacology and pharmacogenomics (including drug discovery and design)
3. Lipid biology
  • Pharmacology
  • Cell biology
  • Biochemical
1. obesity
2. drug addiction
3. neurodegeneration
Cordomí Arnau
Universitat Autònoma de Barcelona
ESwg1, wg2, wg3, wg4, wg51. Molecular mechanisms of signalling pathways
2. Molecular mechanisms of signalling pathways
3. Macromolecular complexes
  • Structural
  • Chemistry
  • Biophysical
1. dimers
2. signaling complexes
3. signal transduction
Kan Beki
Acibadem Mehmet Ali Aydinlar University
TRwww.acibadem.edu.trwg1, wg2, wg3, wg4, wg51. Cell signalling and signal transduction
2. Cell signalling and signal transduction
3. Cell death (including senescence) and autophagy
  • Biochemical
  • Cell biology
  • Biophysical
1. GPCR signaling and G proteins
2. Neurodegeneration
3. Autophagy and mitophagy
van der Es Daan
Leiden University
falsewg1, wg2, wg3, wg4, wg51. Organic chemistry
2. Organic chemistry
3. Biological chemistry
  • Chemistry
  • Chemistry
  • Chemistry
Sylte Ingebrigt
UiT The Arctic University of Norway
NOhttps://en.uit.no/forskning/forskningsgrupper/gruppe?p_document_id=355978wg1, wg2, wg3, wg4, wg51. Pharmacology and pharmacogenomics (including drug discovery and design)
2. Pharmacology and pharmacogenomics (including drug discovery and design)
3. Molecular mechanisms of signalling pathways
  • Computational
  • Computational
  • Computational
1. G-protein coupled receptors
2. Transporter proteins
3. Molecular mechanisms
golebiowski jerome
U cote d azur
FRhttp://chemosim.unice.fr/index.php/golebiowski/wg1, wg2, wg3, wg4, wg51. Theoretical and computational chemistry
2. Theoretical and computational chemistry
3. Scientific computing, simulation and modelling tools
  • Computational
  • Structural
  • Pharmacology
1. smell
2. taste
Nemec Katarina
Max Delbrück Center for Molecular Medicine
DEhttps://www.mdc-berlin.de/lohsewg1, wg2, wg3, wg4, wg51. Biological chemistry
2. Biological chemistry
3. Pharmacology and pharmacogenomics (including drug discovery and design)
  • Pharmacology
  • Cell biology
  • Biochemical
1. GPCR
2. RAMP
3. HTS
Biebermann Heike
Charité Universitätsmedizin Berlin
ALwww.demokritos.grwg1, wg2, wg3, wg4, wg51. Molecular mechanisms of signalling pathways
2. Molecular mechanisms of signalling pathways
3. 1. Mathematics (applications in science and industry)
  • Pharmacology
  • Cell biology
  • Biochemical
1. signalling modulation
2. biased signaling
3. pathway selected ligands
Georgoussi Zafiroula-Iro
National Centre for Sceintific Research "Demokritos"
GRwww.demokritos.grwg1, wg2, wg3, wg4, wg51. Molecular mechanisms of signalling pathways
2. Molecular mechanisms of signalling pathways
3. Neural cell function, communication and signalling, neurotransmission
  • Cell biology
  • Pharmacology
  • Biochemical
1. Opioid receptors
2. G and RGS proteins and effectors
3. G protein signaling-dependent behaviors
Vachkova Ekaterina
Trakia University
BGhttp://uni-sz.bg/engl/about-us/the-university/information/wg1, wg2, wg3, wg4, wg51. Stem cell biology
2. Stem cell biology
3. Molecular mechanisms of signalling pathways
  • Cell biology
  • Animal models
  • Biochemical
1. stem cells
2. adipose tissue
3. regenerative medicine
Schiedel Anke
University of Bonn
DEwg1, wg2, wg3, wg4, wg51. Molecular mechanisms of signalling pathways
2. Molecular mechanisms of signalling pathways
3. 1. Mathematics (applications in science and industry)
  • Cell biology
  • Pharmacology
  • Computational
1. GPCR
2. signal transduction
3. protein protein interactions
DOGAN SONER
Yeditepe University, School of Medicine
TRwww.yeditepe.edu.trwg1, wg2, wg3, wg4, wg51. Molecular mechanisms of signalling pathways
2. Molecular mechanisms of signalling pathways
3. Epigenetics and gene regulation
  • Animal models
  • Cell biology
  • Biochemical
1. Epigenetics
2. Ageing
3. Calorie restriction
IJzerman Ad
Leiden University
falsewg1, wg2, wg3, wg4, wg51. Medicinal chemistry
2. Medicinal chemistry
3. Molecular mechanisms of signalling pathways
  • Pharmacology
  • Chemistry
  • Computational
1. target binding kinetics
2. allosteric modulation
3. GPCR structure
ALMERICO ANNA MARIA
University of Palermo
ITwww.unipa.itwg1, wg2, wg3, wg4, wg51. Method development in chemistry
2. Method development in chemistry
3. Bioinformatics
  • Computational
  • Chemistry
  • Biochemical
1. drug design and synthesis
2. QSAR and SAR analysis
3. antitumor/antivirus/antimicrobial agents
STOEBER MIRIAM
University of Geneva
CHhttps://www.unige.ch/medecine/phym/en/groupes/miriam-stoeber/wg1, wg2, wg3, wg4, wg51. Cell signalling and signal transduction
2. Cell signalling and signal transduction
3. Neural cell function, communication and signalling, neurotransmission
  • Cell biology
  • Biochemical
  • Pharmacology
1. Subcellular Location
2. Signal Transduction
3. Neuropharmacology
Chung Ka Young
Sungkyunkwan University
falsewg1, wg2, wg3, wg4, wg51. Structural biology and its methodologies (e.g. crystallography, cryo-EM, NMR and new technologies)
2. Structural biology and its methodologies (e.g. crystallography, cryo-EM, NMR and new technologies)
3. Cell signalling and signal transduction
  • Structural
  • Biochemical
  • Cell biology
1. GPCR signaling
2. Protein conformation
Ronken Ago
University of Tartu
ALgpcr.ut.eewg1, wg2, wg3, wg4, wg51. Molecular biophysics (e.g. single-molecule approaches, bioenergetics, fluorescence)
2. Molecular biophysics (e.g. single-molecule approaches, bioenergetics, fluorescence)
3. Neural cell function, communication and signalling, neurotransmission
  • Pharmacology
  • Biophysical
  • Biochemical
1. kinetic mechanism of ligand binding
2. Regulation of ligand binding and signal transduction
3. Novel methods for receptor research
Goudet Cyril
Institut de Genomique Fonctionnelle
FRhttp://www.igf.cnrs.frwg1, wg2, wg3, wg4, wg51. Neural cell function, communication and signalling, neurotransmission
2. Neural cell function, communication and signalling, neurotransmission
3. Molecular mechanisms of signalling pathways
  • Pharmacology
  • Pharmacology
  • Animal models
1. GPCR
2. Pain
3. Neuromodulation
Bock Andreas
Max-Delbrueck-Center for Molecular Medicine
DEhttps://www.mdc-berlin.dewg1, wg2, wg3, wg4, wg51. Molecular mechanisms of signalling pathways
2. Molecular mechanisms of signalling pathways
3. Biochemistry
  • Pharmacology
  • Biochemical
  • Biophysical
1. Compartmentalization
2. G protein-coupled receptors
3. Biomolecular condensates
Hilger Daniel
Philipps University of Marburg
DEwg1, wg2, wg3, wg4, wg51. Molecular biophysics (e.g. single-molecule approaches, bioenergetics, fluorescence)
2. Molecular biophysics (e.g. single-molecule approaches, bioenergetics, fluorescence)
3. Structural biology and its methodologies (e.g. crystallography, cryo-EM, NMR and new technologies)
  • Biophysical
  • Biochemical
  • Structural
1. GPCRs
2. Structural dynamics
3. molecular basis of GPCR signaling
KELES Didem
Izmir University of Economics
TRwg1, wg2, wg3, wg4, wg51. Fundamental mechanisms underlying cancer
2. Fundamental mechanisms underlying cancer
3. Molecular mechanisms of signalling pathways
  • Biochemical
  • Biochemical
  • Cell biology
1. Cancer metastasis and extracellular matrix
2. Drug repurposing
3. Voltage gated sodium channels and signaling
Sposini Silvia
CNRS
FRwg1, wg2, wg3, wg4, wg51. Organelle biology and trafficking
2. Organelle biology and trafficking
3. Cell signalling and signal transduction
  • Biophysical
  • Pharmacology
  • Cell biology
1. GPCR
2. Membrane Trafficking
3. Endosomal signalling
Barki-Harrington Liza
University of Haifa
ILwg1, wg2, wg3, wg4, wg51. Protein synthesis, modification, turnover
2. Protein synthesis, modification, turnover
3. Biochemistry
  • Biochemical
  • Cell biology
  • Pharmacology
1. GPCR
2. cyclooxygenase
3. protease
Haran Tali
Technion
ILwg1, wg2, wg3, wg4, wg51. Molecular architecture and structure
2. Molecular architecture and structure
3. 4. Molecular Biology, Biochemistry, Structural Biology and Molecular Biophysics
  • Biophysical
  • Structural
  • Computational
1. Protein-DNA interactions
2. P53 functionality
3. Gene regulation
martinez Karen
University of Copenhagen
DKwg1, wg2, wg3, wg4, wg51. Cell signalling and signal transduction
2. Cell signalling and signal transduction
3. Surface science and nanostructures
  • Biophysical
  • Computational
  • Computational
Abboud Dayana
University of liege
ALwg1, wg2, wg3, wg4, wg51. Cell signalling and signal transduction
2. Cell signalling and signal transduction
3. Metabolism, biological basis of metabolism-related disorders
  • Pharmacology
  • Animal models
  • Biochemical
1. GPCR
2. Orphan GPCR
3. Signal transduction
Jonas Kim
King’s College London
GBwg1, wg2, wg3, wg4, wg51. Molecular mechanisms of signalling pathways
2. Molecular mechanisms of signalling pathways
3. Molecular aspects of endocrinology
  • Cell biology
  • Pharmacology
  • Biochemical
1. GPCRs
2. Endocrinology
3. Cellular signalling
Kozielewicz Pawel
Karolinska Institutet
SEwg1, wg2, wg3, wg4, wg51. Pharmacology and pharmacogenomics (including drug discovery and design)
2. Pharmacology and pharmacogenomics (including drug discovery and design)
3. Biocomputing and molecular computation
  • Pharmacology
  • Cell biology
  • Computational
1. GPCRs
2. small ligands
3. drug discovery
Kukaj Taulant
Friedrisch Schiller University Jena
DEwg1, wg2, wg3, wg4, wg51. Molecular architecture and structure
2. Molecular architecture and structure
3. Medicinal chemistry
  • Biophysical
  • Cell biology
  • Pharmacology
Kosloff Mickey
University of Haifa
ILhttp://koslofflab.haifa.ac.il/index.htmlwg1, wg2, wg3, wg4, wg51. Molecular mechanisms of signalling pathways
2. Molecular mechanisms of signalling pathways
3. Macromolecular complexes
  • Computational
  • Biochemical
  • Structural
1. G proteins, GAPs, effectors
2. Interaction specificity
3. Signaling complexes
Chevigné Andy
Luxembourg Institute of Health
ALwg1, wg2, wg3, wg4, wg51. Molecular mechanisms of signalling pathways
2. Molecular mechanisms of signalling pathways
3. Pharmacology and pharmacogenomics (including drug discovery and design)
  • Cell biology
  • Pharmacology
  • Structural
1. GPCR
2. Chemokine
3. signaling
Szpakowska Martyna
Luxembourg Institute of Health
LUwg1, wg2, wg3, wg4, wg51. Molecular mechanisms of signalling pathways
2. Molecular mechanisms of signalling pathways
3. Pharmacology and pharmacogenomics (including drug discovery and design)
  • Cell biology
  • Pharmacology
  • Structural
1. GPCR
2. Chemokines
Niv Masha
The Hebrew University of Jerusalem, Israel
ILhttps://biochem-food-nutrition.agri.huji.ac.il/mashanivwg1, wg2, wg3, wg4, wg51. Biochemistry
2. Biochemistry
3. Food sciences
  • Computational
  • Behavioral
  • Chemistry
1. GPCRs
2. taste receptors
3. drug discovery
Lane Rob
University of Nottingham
GBhttps://www.nottingham.ac.uk/life-sciences/people/rob.lanewg1, wg2, wg3, wg4, wg51. Pharmacology and pharmacogenomics (including drug discovery and design)
2. Pharmacology and pharmacogenomics (including drug discovery and design)
3. Fundamental aspects of synthetic biology and chemical biology
  • Pharmacology
  • Cell biology
  • Structural
Lamghari Meriem
Institute Of Biomedical Engineering/Institute for Research and Innovation in Health Sciences
PTwww.i3s.up.ptwg1, wg2, wg3, wg4, wg51. Molecular mechanisms of signalling pathways
2. Molecular mechanisms of signalling pathways
3. 7. Physiology, Pathophysiology and Endocrinology
  • Cell biology
  • Animal models
  • Cell biology
Di Pizio Antonella
Leibniz-Institute for Food Systems Biology at TUM
DEhttps://www.leibniz-lsb.de/en/institute/staff/profile-dr-antonella-di-pizio/wg1, wg2, wg3, wg4, wg51. Food sciences
2. Food sciences
3. Medicinal chemistry
  • Computational
  • Structural
  • Chemistry
Vardjan Nina
University of Ljubljana, Faculty of Medicine
SIwg1, wg2, wg3, wg4, wg51. 8. Neuroscience and Neural Disorders
2. 8. Neuroscience and Neural Disorders
3. 4. Molecular Biology, Biochemistry, Structural Biology and Molecular Biophysics
  • Cell biology
  • Biochemical
  • Animal models
1. Astroglia physiology
2. GPCR-mediated cell signalling, metabolism, exocytosis
3. Neuorodegeneration
Calebiro Davide
University of Birmingham
GBhttps://www.birmingham.ac.uk/staff/profiles/metabolism-systems/calebiro-davide.aspxwg1, wg2, wg3, wg4, wg51. Cell signalling and signal transduction
2. Cell signalling and signal transduction
3. Molecular aspects of endocrinology
  • Biophysical
  • Pharmacology
  • Computational
1. GPCRs
2. cAMP
3. signal compartmentalization
Floor Martin
University of Vic
EShttps://urecerca.uvic.cat/CawDOS/jsf/seleccionPersonalEstamento/seleccionPersonal.jsf?id=65989266cd5532c3&idioma=en&tipo=grupo&elmeucv=Nwg1, wg2, wg3, wg4, wg51. Biocomputing and molecular computation
2. Biocomputing and molecular computation
3. Fundamental aspects of synthetic biology and chemical biology
  • Biochemical
  • Biophysical
  • Computational
1. Protein design
2. Enzyme design
3. Structural bioinformatics
Kan Beki
Acibadem Mehmet Ali Aydinlar University
TRwww.acibadem.edu.trwg1, wg2, wg3, wg4, wg51. Cell signalling and signal transduction
2. Cell signalling and signal transduction
3. Cell death (including senescence) and autophagy
  • Biochemical
  • Cell biology
  • Biophysical
1. GPCRs and G proteins
2. Neurodegeneration
3. Autophagy
Villà-Freixa Jordi
Universitat Internacional de Catalunya
ALhttp://www.uic.es/en/medicine-health-sciences/researchwg1, wg2, wg3, wg4, wg51. Chemical reactions: mechanisms, dynamics, kinetics and catalytic reactions
2. Chemical reactions: mechanisms, dynamics, kinetics and catalytic reactions
3. Physical chemistry
  • Computational
  • Structural
  • Biochemical
1. Enzyme catalysis
2. Molecular Dynamics
3. Protein-Protein Interactions
Isbilir Ali
Max Delbrück Center for Molecular Medicine
DEwg1, wg2, wg3, wg4, wg51. Molecular biophysics (e.g. single-molecule approaches, bioenergetics, fluorescence)
2. Molecular biophysics (e.g. single-molecule approaches, bioenergetics, fluorescence)
3. Molecular aspects of endocrinology
  • Pharmacology
  • Cell biology
  • Biophysical
van Westen Gerard
Leiden University (LACDR)
ALwww.cddl.nlwg1, wg2, wg3, wg4, wg51. Artificial intelligence, intelligent systems, multi agent systems
2. Artificial intelligence, intelligent systems, multi agent systems
3. Medicinal chemistry
  • Computational
  • Computational
  • Computational
1. neural-networks
2. GPCRs
3. oncology
Morra Giulia
Consiglio Nazionale delle Ricerche
ITwg1, wg2, wg3, wg4, wg51. Biocomputing and molecular computation
2. Biocomputing and molecular computation
3. Pharmacology and pharmacogenomics (including drug discovery and design)
  • Computational
  • Computational
  • Computational
1. Modeling of allosteric phenomena
2. protein dynamics
3. Drug discovery
Nygaard Mads Mørup
University of Copenhagen
DKwg1, wg2, wg3, wg4, wg51. Scientific computing, simulation and modelling tools
2. Scientific computing, simulation and modelling tools
3. Biochemistry
  • Structural
  • Computational
  • Computational
1. Peptides
2. Simulations
leroy xavier
Domain Therapeutics
FRwww.domaintherapeutics.comwg1, wg2, wg3, wg4, wg51. Innate immunity
2. Innate immunity
3. Molecular biophysics (e.g. single-molecule approaches, bioenergetics, fluorescence)
  • Pharmacology
  • Biochemical
  • Animal models
Maccallini Cristina
University G. d'Annunzio of Chieti-Pescara
ITwg1, wg2, wg3, wg4, wg51. Medicinal chemistry
2. Medicinal chemistry
3. Analytical chemistry
  • Chemistry
  • Biochemical
  • Pharmacology
1. Synthesis
2. small molecules
3. nitric oxide
Munk Christian
Copenhagen University
DKhttps://drug.ku.dkwg1, wg2, wg3, wg4, wg51. Bioinformatics
2. Bioinformatics
3. Machine learning
  • Computational
  • Computational
  • Computational
1. GPCRs
2. Biased signalling
3. Structure analysis
Iatrou Kostas
National Centre for Scientific Research "Demokritos"
GRwww.demokritos.grwg1, wg2, wg3, wg4, wg51. Molecular mechanisms of signalling pathways
2. Molecular mechanisms of signalling pathways
3. Sensation and perception
  • Biochemical
  • Pharmacology
  • Behavioral
1. insects
2. odorant receptors
3. olfactory function modulators
Kirovski Danijela
University of Belgrade
RSwww.vet.bg.ac.rswg1, wg2, wg3, wg4, wg51. Molecular aspects of endocrinology
2. Molecular aspects of endocrinology
3. Metabolomics
  • Animal models
  • Biochemical
  • Clinical
1. Domestic animals
2. cell signaling
3. metabolism
Stoddart Leigh
University of Nottingham
GBwg1, wg2, wg3, wg4, wg51. Cell signalling and signal transduction
2. Cell signalling and signal transduction
3. Pharmacology and pharmacogenomics (including drug discovery and design)
  • Pharmacology
  • Biophysical
  • Pharmacology
1. Binding kinetics
2. Membrane organisation of receptors
3. GPCR fluorescent ligands
Feeney Emma
University College Dublin
IEwg1, wg2, wg3, wg4, wg51. Sensation and perception
2. Sensation and perception
3. Epidemiology and public health
  • Behavioral
  • Structural
  • Clinical
1. taste perception
2. sensory evaluation
3. food structure
Lacivita Enza
University of Bary
ITwg1, wg2, wg3, wg4, wg51. Medicinal chemistry
2. Medicinal chemistry
3. Neuronal development, plasticity and regeneration
  • Chemistry
  • Pharmacology
  • Computational
1. GPCRs
2. neuroinflammation
3. biased agonism
Innamorati Giulio
University of Verona
ITwg1, wg2, wg3, wg4, wg51. Cell signalling and signal transduction
2. Cell signalling and signal transduction
3. Molecular mechanisms of signalling pathways
  • Cell biology
  • Biochemical
  • Pharmacology
pardo leonardo
universidad autonoma de barcelona
ESlmc.uab.eswg1, wg2, wg3, wg4, wg51. Computational biology
2. Computational biology
3. Bioinformatics
  • Computational
  • Computational
  • Computational
1. oligomerization
2. drug design
Waldhoer Maria
InterAx Biotech
CHwww.interaxbiotech.comwg1, wg2, wg3, wg4, wg51. Molecular mechanisms of signalling pathways
2. Molecular mechanisms of signalling pathways
3. Computational biology
  • Pharmacology
  • Cell biology
  • Computational
Prömel Simone
Leipzig University
DEhttp://biochemie.medizin.uni-leipzig.de/mbch_cms/index.php/forschung/forschungsschwerpunkte-2/forschungsschwerpunkte-5wg1, wg2, wg3, wg4, wg51. Biochemistry
2. Biochemistry
3. Metabolism, biological basis of metabolism-related disorders
  • Animal models
  • Cell biology
  • Biochemical
1. Adhesion GPCRs
2. Signalling
3. Physiological functions
Sensoy Ozge
Istanbul Medipol University
TRsensoylab@medipol.edu.trwg1, wg2, wg3, wg4, wg51. Scientific computing, simulation and modelling tools
2. Scientific computing, simulation and modelling tools
3. Cell signalling and signal transduction
  • Computational
  • Biophysical
  • Structural
1. GPCR biased signaling
2. Neurological disorders
3. Cancer
Ghosh Eshan
Copenhagen University
DKhttps://drug.ku.dk/wg1, wg2, wg3, wg4, wg51. Structural biology and its methodologies (e.g. crystallography, cryo-EM, NMR and new technologies)
2. Structural biology and its methodologies (e.g. crystallography, cryo-EM, NMR and new technologies)
3. Fundamental aspects of synthetic biology and chemical biology
  • Biochemical
  • Cell biology
  • Structural
1. GPCR Structural Biology
2. Macromolecular Assembly
3. Protein Evolution
Bonnesen Cecilie
University of Copenhagen
DKwg1, wg2, wg3, wg4, wg51. 4. Molecular Biology, Biochemistry, Structural Biology and Molecular Biophysics
2. 4. Molecular Biology, Biochemistry, Structural Biology and Molecular Biophysics
3.
  • Structural
  • Structural
  • Biochemical
Simon Icaro Ariel
University of Copenhagen
DKwg1, wg2, wg3, wg4, wg51. 4. Molecular Biology, Biochemistry, Structural Biology and Molecular Biophysics
2. 4. Molecular Biology, Biochemistry, Structural Biology and Molecular Biophysics
3. Biocomputing and molecular computation
  • Computational
  • Chemistry
  • Structural
1. molecular modeling
2. gpcr
3. biased signalling
Ballante Flavio
Uppsala University
SEhttps://www.icm.uu.se/?languageId=1wg1, wg2, wg3, wg4, wg51. Theoretical and computational chemistry
2. Theoretical and computational chemistry
3. Scientific computing, simulation and modelling tools
  • Computational
  • Computational
  • Computational
1. Drug design
2. Computational chemistry
3. Medicinal chemistry
Krause Gerd
Leibniz-Forschungsinstitut für molekulare Pharmakologie (FMP)
DEhttps://www.leibniz-fmp.de/GKrausewg1, wg2, wg3, wg4, wg51. Molecular architecture and structure
2. Molecular architecture and structure
3. Molecular aspects of endocrinology
  • Pharmacology
  • Structural
  • Computational
1. membrane proteins
2. structure-function relationshipss
3. pharmacological intervention
Jockers Ralf
University of Paris
ALhttps://www.institutcochin.fr/departments/emd/team-jockers?set_language=enwg1, wg2, wg3, wg4, wg51. Pharmacology and pharmacogenomics (including drug discovery and design)
2. Pharmacology and pharmacogenomics (including drug discovery and design)
3. Cell signalling and signal transduction
  • Biochemical
  • Pharmacology
  • Animal models
1. GPCR
2. Melatonin
3. Leptin
Bräuner-Osborne Hans
University of Copenhagen
DKhttps://drug.ku.dk/disciplines/molecular-and-cellular-pharmacology/molecular_pharmacology/wg1, wg2, wg3, wg4, wg51. Pharmacology and pharmacogenomics (including drug discovery and design)
2. Pharmacology and pharmacogenomics (including drug discovery and design)
3. 1. Mathematics (applications in science and industry)
  • Pharmacology
  • Computational
  • Computational
1. GPCR
2. molecular pharmacology
3. mechanism-of-action
Mamyrbekov Alibek
University of Copenhagen
DKwg1, wg2, wg3, wg4, wg51. Bioinformatics
2. Bioinformatics
3. Scientific computing, simulation and modelling tools
  • Computational
  • Computational
  • Computational
Leopoldo Marcello
Università degli Studi di Bari Aldo Moro
ALwg1, wg2, wg3, wg4, wg51. Medicinal chemistry
2. Medicinal chemistry
3. Fundamental aspects of synthetic biology and chemical biology
  • Chemistry
  • Pharmacology
  • Animal models
1. Allosteric modulators
2. Orphan Receptors
3. Biased agonists
Harpsøe Kasper
University of Copenhagen
DKgloriamgroup.orgwg1, wg2, wg3, wg4, wg51. Scientific computing, simulation and modelling tools
2. Scientific computing, simulation and modelling tools
3. Bioinformatics
  • Computational
  • Computational
  • Computational
1. Biased agonists
2. Inhibitors of G protein mediated signaling
3. Analysis of ligand binding determinants
Wolber Gerhard
Freie Universitaet Berlin
DEhttp://www.drug-design.dewg1, wg2, wg3, wg4, wg51. Medicinal chemistry
2. Medicinal chemistry
3.
  • Computational
  • Chemistry
  • Structural
1. virtual screening
2. dynophores
3. functional selectivity
Vavers Edijs
Latvian Institute of Organic Synthesis
LVhttp://www.osi.lv/en/wg1, wg2, wg3, wg4, wg51. Neurological disorders
2. Neurological disorders
3. Molecular mechanisms of signalling pathways
  • Pharmacology
  • Animal models
  • Behavioral
1. Sigma-1 chaperone protein
2. Epileptogenesis
3. Novel compounds
Saraiva Nuno
Universidade Lusófona
PThttp://cbios.ulusofona.pt/wg1, wg2, wg3, wg4, wg51. Cell signalling and signal transduction
2. Cell signalling and signal transduction
3. Cytoskeleton and cell behaviour
  • Cell biology
  • Cell biology
  • Cell biology
1. ROS and Ca2+ signalling
2. Cell motility
3. Cancer progression
Rosenkilde Mette
UCPH
DKwww.sund.ku.dkwg1, wg2, wg3, wg4, wg51. 4. Molecular Biology, Biochemistry, Structural Biology and Molecular Biophysics
2. 4. Molecular Biology, Biochemistry, Structural Biology and Molecular Biophysics
3. Biological chemistry
  • Pharmacology
  • Biochemical
  • Clinical
Gutierrez de Teran Hugo
Uppsala University
ALhttp://open.gpcr-modsim.org/wg1, wg2, wg3, wg4, wg51. Theoretical and computational chemistry
2. Theoretical and computational chemistry
3. Biocomputing and molecular computation
  • Computational
  • Structural
  • Chemistry
1. GPCR
2. Free Energy
3. adenosine receptors
Acher Francine
University Paris Descartes
FRhttp://www.biomedicale.parisdescartes.fr/umr8601/Research-292.htmlwg1, wg2, wg3, wg4, wg51. Medicinal chemistry
2. Medicinal chemistry
3. Neurological disorders
  • Chemistry
  • Pharmacology
  • Structural
1. glutamate
2. GPCRs
3. transporters
Mathiesen Jesper
Zealand Pharma
DKwg1, wg2, wg3, wg4, wg51. Molecular mechanisms of signalling pathways
2. Molecular mechanisms of signalling pathways
3. Cell signalling and signal transduction
  • Pharmacology
  • Biochemical
  • Structural
Tiemann Johanna
University Leipzig
DEwg1, wg2, wg3, wg4, wg51. Scientific computing, simulation and modelling tools
2. Scientific computing, simulation and modelling tools
3. Computer graphics, computer vision, multi media
  • Computational
  • Structural
  • Pharmacology
1. GPCR dynamics
2. Dynamic network
3. Knowledge collection
FOGEL Wieslawa Agnieszka
Medical University of Lodz
PLhttps://umed.pl/wg1, wg2, wg3, wg4, wg51. 1. Mathematics (applications in science and industry)
2. 1. Mathematics (applications in science and industry)
3. 1. Mathematics (applications in science and industry)
  • Animal models
  • Pharmacology
  • Biochemical
1. CNS disorders
2. animal models
3. GPCRs ligands
FOGEL Wieslawa Agnieszka
Medical University of Lodz
PLhttps://umed.pl/wg1, wg2, wg3, wg4, wg51. 1. Mathematics (applications in science and industry)
2. 1. Mathematics (applications in science and industry)
3. 1. Mathematics (applications in science and industry)
  • Animal models
  • Pharmacology
  • Biochemical
1. CNS disorders
2. animal models
3. GPCRs ligands
Hansen Trond Vidar
University of Oslo
NOhttps://www.mn.uio.no/farmasi/english/research/groups/lipchem/wg1, wg2, wg3, wg4, wg51. 2. Physics and Chemistry
2. 2. Physics and Chemistry
3. Biological chemistry
  • Chemistry
  • Structural
  • Biochemical
1. Medicinal chemistry
2. Agonists
3. Resolution of inflammation
Wozniak Monika
University in Liege
BEwg1, wg2, wg3, wg4, wg51. 4. Molecular Biology, Biochemistry, Structural Biology and Molecular Biophysics
2. 4. Molecular Biology, Biochemistry, Structural Biology and Molecular Biophysics
3. 6. Cellular and Developmental Biology
  • Pharmacology
  • Biochemical
  • Cell biology
Guccione Salvatore
Catania
ALhttp://www.dsf.unict.it/wg1, wg2, wg3, wg4, wg51. Medicinal chemistry
2. Medicinal chemistry
3. Organic chemistry
  • Computational
  • Computational
  • Computational
1. Drug Design
2. Drug synthesis
3.
Laurenzana Anna
University of Florence
ALwg1, wg2, wg3, wg4, wg51. Fundamental mechanisms underlying cancer
2. Fundamental mechanisms underlying cancer
3. Epigenetics and gene regulation
  • Cell biology
  • Biochemical
  • Animal models
1. Cancer
2. signaling pathways
3. Gene regulation
Shahraki Aida
Bogazici university
TRwg1, wg2, wg3, wg4, wg51. 4. Molecular Biology, Biochemistry, Structural Biology and Molecular Biophysics
2. 4. Molecular Biology, Biochemistry, Structural Biology and Molecular Biophysics
3. Computational biology
  • Computational
  • Structural
  • Pharmacology
1. high-throughput virtual screening
2. peptide-based agonists
3. structural studies
Bondar Alexey
Center for Nanobiology and Structural Biology
CZwg1, wg2, wg3, wg4, wg51. Cell signalling and signal transduction
2. Cell signalling and signal transduction
3. Molecular mechanisms of signalling pathways
  • Biophysical
  • Cell biology
  • Biochemical
1. clathrin
2. single-molecule imaging
3. preassembly
Voß Jan Hendrik
University of Bonn
DEwg1, wg2, wg3, wg4, wg51. Molecular mechanisms of signalling pathways
2. Molecular mechanisms of signalling pathways
3.
  • Pharmacology
  • Biochemical
  • Computational
1. Binding kinetics
2. Structure-function relationship
3.
Zorec Robert
Univerza v Ljubljani, Medicinska fakulteta
SIwg1, wg2, wg3, wg4, wg51. Organelle biology and trafficking
2. Organelle biology and trafficking
3. 7. Physiology, Pathophysiology and Endocrinology
  • Cell biology
  • Biophysical
  • Pharmacology
1. membrane fusion
2. astrocytes and neurodegeneration
3. cancer cell vaccine
Alves, Isabel
U. of Bordeaux
PTWG1, WG21. Molecular biophysics
2. Biological chemistry
3. Psychiatric disorders
  • Biophysical/plasmon waveguide resonance
  • Biochemical/signal transduction cascades
  • Biophysical/Calorimetry

1. lipid impact in signal transduction
2. ligand-receptor interaactions
3. cryo EM, sensor technologies, in cell FRET
Kandemis, Emine
Bahçeşehir University
TRhttps://bit.ly/2MNhRKqWG21. Molecular mechanisms of signalling pathways
2. Cell signalling and signal transduction
3. Non-coding RNAs
  • Computational
  • Computational
  • Computational

1. Cancer Biology
2. Cell signaling
3. LncRNAs
Corminboeuf, Olivier
Idorsia Pharmaceuticals Ltd
FRwww.idorsia.comWG1, WG2, WG3, WG41. Medicinal chemistry
2. Immunological mechanisms in disease
3. Pharmacology and pharmacogenomics
  • Chemistry
  • Biochemical
  • Pharmacology

1. Medicinal Chemistry
2. Oncology
3. Immunology
Carlsson, Jens
Uppsala University
SEhttp://www.carlssonlab.org WG3, WG4, WG51. Bioinformatics
2. Medicinal chemistry
3. Theoretical and computational chemistry
  • Computational
  • Computational
  • Computational

1. Polypharmacology/Selective/Biased ligands
2. Structural basis of GPCR activation
3. Accurate structural models of ALL GPCRs
Mordalski, Stefan
University of Copenhagen
DKWG1, WG31. Molecular mechanisms of signalling pathways
2. Structural biology and its methodologies (e.g. crystallography, cryo-EM, NMR and new technologies)
Up to three techniques of expertise - First
  • Computational
  • Computational
  • Computational

Contino, Marialessandra
University of Bari
ITWG3, WG41. Biological chemistry
2. Molecular mechanisms of signalling pathways
3. Neurological disorders
  • Pharmacology
  • Biochemical
  • Cell biology

1. GPCRs
2. Cancer
3. Neurodegeneration
Sommer, Martha
Charité Medical University Berlin
DEhttps://biophysik.charite.deWG1, WG21. Molecular mechanisms of signalling pathways
2. Molecular biophysics (e.g. single-molecule approaches, bioenergetics, fluorescence)
3. Biochemistry
  • Biophysical
  • Biochemical
  • Biochemical

1. Arrestin activation mechanism
2. Arrestin-GPCR interactions
3. Biological roles of arrestin
Hamann, Jörg
Amsterdam University Medical Centers
NLWG21. Immunological mechanisms in disease
2. Regulation and effector functions of the immune response
3. Molecular mechanisms of signalling pathways
  • Cell biology
  • Animal models
  • Clinical

1. Adhesion GPCRs
2. Microglia
3. T cells
Bennett, Kirstie
Sosei Heptares
GBwww.soseiheptares.comWG31. Molecular Biology, Biochemistry, Structural Biology and Molecular Biophysics
2. Cellular and Developmental Biology
3. Mathematics (applications in science and industry)
  • Pharmacology
  • Cell biology
  • Computational

1. GPCR
2. Molecular Pharmacology
Tautermann, Christofer
Boehringer Ingelheim Pharma GmbH & Co KG
ALWG2, WG31. Theoretical and computational chemistry
2. Medicinal chemistry
3. Scientific computing, simulation and modelling tools
  • Computational
  • Structural
  • Computational

1. Drug design
2. Computational chemistry
3. GPCR models
Chabbert, Marie
CNRS
FRWG11. Computational biology
2. Molecular mechanisms of signalling pathways
3. Bioinformatics
  • Computational
  • Structural
  • Biophysical

1. GPCR
2. Biased Signaling
3. Molecular Simulations
Canals, Meritxell
University of Nottingham
GBWG1, WG2, WG3, WG41. Molecular mechanisms of signalling pathways
2. Pharmacology and pharmacogenomics (including drug discovery and design)
3. Molecular biophysics (e.g. single-molecule approaches, bioenergetics, fluorescence)
  • Pharmacology
  • Cell biology
  • Biochemical

1. Opioid receptors
2. GPCRs
3. Signalling
Liebscher, Ines
Leipzig University
DEWG1, WG21. Molecular Biology, Biochemistry, Structural Biology and Molecular Biophysics
2. Molecular mechanisms of signalling pathways
3. Biochemistry
  • Biochemical
  • Pharmacology
  • Animal models

1. Adhesion GPCR
2. Mechano-activation
3. Deorphanization
Solano, Maria Marti
MRC Laboratory of Molecular Biology
GBWG1, WG31. Molecular mechanisms of signalling pathways
2. Computational biology
3. Systems biology
  • Computational
  • Structural
  • Pharmacology

1. Pharmacogenomics
2. Signalling bias
3. Structural Biology
Kolb, Peter
Philipps-University Marburg
DEwww.kolblab.orgWG3, WG51. Pharmacology and pharmacogenomics (including drug discovery and design)
2. Medicinal chemistry
3. Scientific computing, simulation and modelling tools
  • Computational
  • Structural
  • Pharmacology

1. Ligand selectivity
2. Prediction of affinity/efficacy/bias
3. Chemical universe
Hauser, Alexander
University of Copenhagen
DKWG1, WG2, WG3, WG4, WG51. Bioinformatics
2. Systems biology
3. Pharmacology and pharmacogenomics (including drug discovery and design)
  • Computational
  • Structural
  • Biophysical

1. GPCRs
2. Pharmacogenomics
3. Structure Biology
Fardilha, Margarida
University of Aveiro
PTwww.ua.ptWG2, WG31. Biochemistry
2. Genetics, ’Omics’, Bioinformatics and Systems Biology
3. Physiology, Pathophysiology and Endocrinology
  • Biochemical
  • Cell biology
  • Clinical

1. Male reproduction
2. Sperm motility
3. Protein phosphatase 1
Žerovnik, Eva
Institute "Jožef Stefan"
SIWG1, WG3, WG4, 1. Physical chemistry of biological systems
2. Biological chemistry
3. Nanophysics
  • Biochemical
  • Biophysical
  • Cell biology

1. Protein folding
2. Protein aggregation
3. Cascade of neurodegeneration
Lazar, Josef
Institute of Organic Chemistry and Biochemistry CAS
CZwww.uochb.czWG1, WG2, WG3, WG41. Molecular biophysics (e.g. single-molecule approaches, bioenergetics, fluorescence)
2. Cell signalling and signal transduction
3. Spectroscopic and spectrometric techniques
  • Biophysical
  • Cell biology
  • Structural

1. Cell signaling
2. Advanced optical microscopy
3. G proteins
Plouffe, Bianca
Queen's University Belfast
GBhttps://pure.qub.ac.uk/WG2, WG31. Cell signalling and signal transduction
2. Fundamental mechanisms underlying cancer
3. Fundamental mechanisms underlying cardiovascular diseases
  • Pharmacology
  • Cell biology
  • Cell biology

1. Compartmentalised G protein signalling
2. GPCR signalling
Paparde, Artūrs
Rīga Stradiņš university
LVwww.rsu.lvWG21. Fundamental mechanisms underlying cardiovascular diseases
2. Comparative physiology and pathophysiology
3. Organ physiology and pathophysiology
  • Computational
  • Computational
  • Computational

1. Atherosclerosis
2. Cardiovascular adaptation
3. (Patho-) physiology of atherosclerosis
Kellenberger, Esther
Université de Strasbourg
FRhttp://bioinfo-pharma.u-strasbg.frWG31. Molecular Biology, Biochemistry, Structural Biology and Molecular Biophysics
2. Medicinal chemistry
3. Scientific computing, simulation and modelling tools
  • Computational
  • Structural
  • Structural

1. Molecular recognition
2. Structure-activity relationship
3. G-protein coupled receptor
D'Ursi, Pasqualina
National Research Council
ITwww.tb.cnr.itWG11. Molecular architecture and structure
2. Bioinformatics
3. Medicinal chemistry
  • Structural
  • Biochemical
  • Pharmacology

1. Bionformatics
2. Protein structure activity
3. Drug design
Tobin, Andrew
University of Glasgow
GBWG21. Cell signalling and signal transduction
2. Neural cell function, communication and signalling, neurotransmission
3. Pharmacology and pharmacogenomics (including drug discovery and design)
  • Biochemical
  • Pharmacology
  • Cell biology

1. Neuroscience
2. Gut physiology
3. Respiratory disease
Radi, Marco
University of Parma
IThttps://sites.google.com/site/marcoradiWG31. Medicinal chemistry
2. Method development in chemistry
3. Organic chemistry
  • Chemistry
  • Small molecules
  • Docking

1. CCR6
2. CXCR4
3. GPER-1
Murga, Cristina
Universidad Autónoma de Madrid
EShttp://cmurga.cbmso.esWG2, WG31. Cell signalling and signal transduction
2. Metabolism, biological basis of metabolism-related disorders
3. Organ physiology and pathophysiology
  • Biochemical
  • Animal models
  • Cell biology

1. Signalling
2. Pathophysiology
3. Metabolism
Nativi, Cristina
University of Florence
ITwww.unifi.itWG31. Organic chemistry
2. Glycomics/Lipidomics
3. Glycobiology
  • Chemistry
  • Computational
  • Computational

1. In vitro tests
2. Animal model
3. Glycobiology
Osborne, Greg
Heptares Therapeutics
GBwww.soseiheptares.comWG1, WG2, WG3, WG41. Mathematics (applications in science and industry)
2. Mathematics (applications in science and industry)
3. Mathematics (applications in science and industry)
  • Computational
  • Computational
  • Computational

Sotelo, Eddy
University of Santiago de Compostela
EShttps://www.sotelolab.esWG2, WG3, WG41. Medicinal chemistry
2. Biological chemistry
3. Fundamental aspects of synthetic biology and chemical biology
  • Chemistry
  • Chemistry
  • Pharmacology

1. Optimization of new ligands
2. New conjugation strategies
3. Biasedligands, allosteric modulators and bitopic ligands
Tate, Chris
MRC Laboratory of Molecular Biology
GBhttps://www2.mrc-lmb.cam.ac.uk/WG1, WG41. Molecular Biology, Biochemistry, Structural Biology and Molecular Biophysics
2. Macromolecular complexes
3. Structural biology and its methodologies (e.g. crystallography, cryo-EM, NMR and new technologies)
  • Structural
  • Biophysical
  • Biochemical

1. GPCR complexes
2. Structure
3. Dynamics
Bermudez, Marcel
Freie Universität Berlin
DEhttps://www.bcp.fu-berlin.deWG1, WG3, WG51. Pharmacology and pharmacogenomics (including drug discovery and design)
2. Medicinal chemistry
3. Molecular mechanisms of signalling pathways
  • Computational
  • Computational
  • Computational

1. GPCR pharmacology
2. Rational drug design
3. Signal tranduction
Capiod, Thierry
Université Paris-Descartes
FRhttps://www.institut-necker-enfants-malades.fr/WG2, WG31. Cellular and Developmental Biology
2. Physiology, Pathophysiology and Endocrinology
3. Immunity and Infection
  • Cell biology
  • Cell biology
  • Biophysical

1. Prostate
2. Cancer
3. Calcium
Gmeiner, Peter
FAU
DEhttp://www.medchem.fau.de/gmeinerlab/WG31. Medicinal chemistry
2. Neurological disorders
3. Imaging for medical diagnosis
  • Chemistry
  • Pharmacology
  • Computational

1. GPCR ligands
2. Drug discovery
3. Structure based design
Krasel, Cornelius
Philipps-University Marburg
DEhttps://www.uni-marburg.de/de/fb16/ipkpWG11. Molecular mechanisms of signalling pathways
2. Cell signalling and signal transduction
3. Mathematics (applications in science and industry)
  • Pharmacology
  • Biochemical
  • Cell biology

Tikhonova, Irina
Queen's University Belfast
GBhttps://pure.qub.ac.uk/WG1, WG3, WG51. Computational biology
2. Fundamental aspects of synthetic biology and chemical biology
3. Biochemistry
  • Computational
  • Biochemical
  • Pharmacology

1. Allosteric sites
2. Dimerization
3. Drug design
Dubiel, Mariam
Heinrich Heine University of Duesseldorf
DEhttp://www.pharmazie.hhu.deWG11. Pharmacology and pharmacogenomics (including drug discovery and design)
2. Neurological disorders
3. Molecular mechanisms of signalling pathways
  • Pharmacology
  • Biochemical
  • Chemistry

Wessel Andressen, Kjetil
University of Oslo
NOhttps://www.med.uio.no/WG11. Molecular biophysics (e.g. single-molecule approaches, bioenergetics, fluorescence)
2. Molecular mechanisms of signalling pathways
3. Macromolecular complexes
  • Biophysical
  • Biophysical
  • Pharmacology

1. cGMP
2. 5-HT7 receptor
3. Cardiomyocyte
Stefanachi, Angela
Università degli studi di Bari Aldo Moro
IThttps://www.uniba.it/WG3, WG41. Medicinal chemistry
2. Organic chemistry
3. Chemical reactions: mechanisms, dynamics, kinetics and catalytic reactions
  • Chemistry
  • Cell biology
  • Computational

1. CB2
2. Cancer
3. Neurodegeneration
Stark, Holger
Heinrich Heine University Düsseldorf
ALhttp://www.pharmazie.hhu.deWG1, WG2, WG31. Cell signalling and signal transduction
2. Glycomics/Lipidomics
3. Neural cell function, communication and signalling, neurotransmission
  • Chemistry
  • Pharmacology
  • Biochemical

1. Medicinal Chemistry
2. Drug development
3. Neurotransmitter
Cong, Xiaojing
Université Côte d'Azur
FRWG1, WG2, WG31. Theoretical and computational chemistry
2. Physical chemistry of biological systems
3. Bioinformatics
  • Computational
  • Biophysical
  • Chemistry

Nyagulova Kandemish, Emilia
Bahçeşehir University
ALhttp://akademik.bahcesehir.edu.trWG21. Molecular mechanisms of signalling pathways
2. Non-coding RNAs
3. Cell signalling and signal transduction
  • Cell biology
  • Cell biology
  • Cell biology

1. Cell signaling
2. Cancer
3. Non-coding RNAs
Gloriam, David
University of Copenhagen
DKWG3, WG51. Web and information systems, database systems
2. Theoretical and computational chemistry
3. Structural biology and its methodologies (e.g. crystallography, cryo-EM, NMR and new technologies)
  • Computational
  • Structural
  • Pharmacology

1. Open access databases
2. Computational drug design
3. Structure determination
M Keseru, György
Research Center for Natural Sciences
HUhttp://medchem.ttk.hu/WG31. Medicinal chemistry
2. Fundamental aspects of synthetic biology and chemical biology
3. Theoretical and computational chemistry
  • Chemistry
  • Chemistry
  • Computational

1. Medicinal chemistry
2. Chemical biology
3. Drug design
Rafael Franco
Universitat de Barcelona
ALWG1, WG21. Biological chemistry
2. Biochemistry
3. Neural cell function, communication and signalling, neurotransmission
  • Biochemical
  • Pharmacology
  • Biophysical

COST

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

COST Action CA18133

All cells face the vital challenge of sensing their environments and responding in appropriate ways. How are different signalling pathways activated and modulated in precise and reproducible ways? Filling this gap in knowledge is absolutely necessary to advance the next generation of pharmaceutical drugs.

COST Action

COST Action

Pulpit rock

© 2019 ERNEST - All rights reserved. | Design by Boutik

European Research Network on Signal Transduction